Skip to content

Drug interactions

Basiliximab + Influenza virus vaccine quadrivalent recombinant

Severity: Minor

Basiliximab and Influenza virus vaccine quadrivalent recombinant: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Immunosuppression with basiliximab may lower the antibody response to influenza vaccination. The recombinant vaccine is non-live and safe to give, but protection may be reduced.

What this interaction means in plain words

Basiliximab and Influenza virus vaccine quadrivalent recombinant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Moderate

Why it happens

Impaired T-cell dependent immune response to vaccine antigens.

What to do

Vaccinate anyway because it is non-live and still beneficial, ideally before transplant or induction when feasible. Do not rely on vaccine alone in high-risk exposures.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Basiliximab and Influenza virus vaccine quadrivalent recombinant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Basiliximab with Influenza virus vaccine quadrivalent recombinant?

MediHelp rates the interaction as minor. Basiliximab and Influenza virus vaccine quadrivalent recombinant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Immunosuppression with basiliximab may lower the antibody response to influenza vaccination. The recombinant vaccine is non-live and safe to give, but protection may be reduced.

How serious is the interaction between Basiliximab and Influenza virus vaccine quadrivalent recombinant?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccinate anyway because it is non-live and still beneficial, ideally before transplant or induction when feasible. Do not rely on vaccine alone in high-risk exposures.

What other medicines interact with Basiliximab?

MediHelp also lists interactions of Basiliximab with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine. The full list is on the Basiliximab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in